| pubmed-article:16086866 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16086866 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:16086866 | lifeskim:mentions | umls-concept:C0152035 | lld:lifeskim |
| pubmed-article:16086866 | lifeskim:mentions | umls-concept:C0034802 | lld:lifeskim |
| pubmed-article:16086866 | lifeskim:mentions | umls-concept:C0007131 | lld:lifeskim |
| pubmed-article:16086866 | lifeskim:mentions | umls-concept:C0026882 | lld:lifeskim |
| pubmed-article:16086866 | pubmed:issue | 8 | lld:pubmed |
| pubmed-article:16086866 | pubmed:dateCreated | 2005-8-9 | lld:pubmed |
| pubmed-article:16086866 | pubmed:abstractText | Recent studies showed that somatic mutations in epidermal growth factor receptor (EGFR) tyrosine kinase (TK) domain are associated with sensitivity of non-small cell lung cancer(NSCLC) to TK inhibitor gefitinib. The mutations, including in-frame deletions at exon 19 and substitutions at exon 18 or exon 21, cluster around ATP-binding pocket of TK domain. The frequency of mutations are higher in Japanese patients than in American patients. This study was to analyze EGFR mutations in Chinese patients with NSCLC. | lld:pubmed |
| pubmed-article:16086866 | pubmed:language | chi | lld:pubmed |
| pubmed-article:16086866 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16086866 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16086866 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16086866 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16086866 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16086866 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:16086866 | pubmed:issn | 1000-467X | lld:pubmed |
| pubmed-article:16086866 | pubmed:author | pubmed-author:VigoC BCB | lld:pubmed |
| pubmed-article:16086866 | pubmed:author | pubmed-author:ZhangLiL | lld:pubmed |
| pubmed-article:16086866 | pubmed:author | pubmed-author:LiNingN | lld:pubmed |
| pubmed-article:16086866 | pubmed:author | pubmed-author:ZhangXingX | lld:pubmed |
| pubmed-article:16086866 | pubmed:author | pubmed-author:HOLRR | lld:pubmed |
| pubmed-article:16086866 | pubmed:author | pubmed-author:GuanZhong-Zhe... | lld:pubmed |
| pubmed-article:16086866 | pubmed:author | pubmed-author:ChangJian-Hua... | lld:pubmed |
| pubmed-article:16086866 | pubmed:author | pubmed-author:PanZhen-KuiZK | lld:pubmed |
| pubmed-article:16086866 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16086866 | pubmed:volume | 24 | lld:pubmed |
| pubmed-article:16086866 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16086866 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16086866 | pubmed:pagination | 919-23 | lld:pubmed |
| pubmed-article:16086866 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
| pubmed-article:16086866 | pubmed:meshHeading | pubmed-meshheading:16086866... | lld:pubmed |
| pubmed-article:16086866 | pubmed:meshHeading | pubmed-meshheading:16086866... | lld:pubmed |
| pubmed-article:16086866 | pubmed:meshHeading | pubmed-meshheading:16086866... | lld:pubmed |
| pubmed-article:16086866 | pubmed:meshHeading | pubmed-meshheading:16086866... | lld:pubmed |
| pubmed-article:16086866 | pubmed:meshHeading | pubmed-meshheading:16086866... | lld:pubmed |
| pubmed-article:16086866 | pubmed:meshHeading | pubmed-meshheading:16086866... | lld:pubmed |
| pubmed-article:16086866 | pubmed:meshHeading | pubmed-meshheading:16086866... | lld:pubmed |
| pubmed-article:16086866 | pubmed:meshHeading | pubmed-meshheading:16086866... | lld:pubmed |
| pubmed-article:16086866 | pubmed:meshHeading | pubmed-meshheading:16086866... | lld:pubmed |
| pubmed-article:16086866 | pubmed:meshHeading | pubmed-meshheading:16086866... | lld:pubmed |
| pubmed-article:16086866 | pubmed:meshHeading | pubmed-meshheading:16086866... | lld:pubmed |
| pubmed-article:16086866 | pubmed:meshHeading | pubmed-meshheading:16086866... | lld:pubmed |
| pubmed-article:16086866 | pubmed:meshHeading | pubmed-meshheading:16086866... | lld:pubmed |
| pubmed-article:16086866 | pubmed:meshHeading | pubmed-meshheading:16086866... | lld:pubmed |
| pubmed-article:16086866 | pubmed:meshHeading | pubmed-meshheading:16086866... | lld:pubmed |
| pubmed-article:16086866 | pubmed:meshHeading | pubmed-meshheading:16086866... | lld:pubmed |
| pubmed-article:16086866 | pubmed:meshHeading | pubmed-meshheading:16086866... | lld:pubmed |
| pubmed-article:16086866 | pubmed:meshHeading | pubmed-meshheading:16086866... | lld:pubmed |
| pubmed-article:16086866 | pubmed:meshHeading | pubmed-meshheading:16086866... | lld:pubmed |
| pubmed-article:16086866 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:16086866 | pubmed:articleTitle | [Epidermal growth factor receptor mutation in Chinese patients with non-small cell lung cancer]. | lld:pubmed |
| pubmed-article:16086866 | pubmed:affiliation | Skate Key Laboratory of Oncology in Southern China, Cancer Center, Sun Yat-sen University, Guangzhou, Guangdong, P. R. China. | lld:pubmed |
| pubmed-article:16086866 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16086866 | pubmed:publicationType | English Abstract | lld:pubmed |
| pubmed-article:16086866 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
